Behavioral and immunological effects of substance P in female and male mice

Pharmacology Biochemistry and Behavior

Volumn 79, Issue 1, 2004, Pages 1-9

  Teixeira, Raquel M ^a   Duarte, Filipe S ^a   De Lima, Thereza C M ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Lymphocyte distribution; Macrophages; Neurokinin; Nitric oxide; Plus maze; Sex

Indexed keywords

CYTOKINE; NITRIC OXIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; LEUKOCYTE; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; FEMALE; GROOMING; IMMUNITY; INJECTIONS, INTRAVENTRICULAR; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MOTOR ACTIVITY; NEUTROPHILS; NITRIC OXIDE; SEX CHARACTERISTICS; SUBSTANCE P;

ANIMALIA;

EID: 4544293408     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.04.032     Document Type: Article

References (68)

1. Ader R., Felten D., Cohen N. Psychoneuroimmunology. 3rd ed:2001;Academic Press, San Diego (CA)
2. Aguiar M.S., Brandão M.L. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test. Physiol. Behav. 60:1996;1183-1186
3. Archer J. Rodent sex differences in emotional and related behavior. Behav. Biol. 14:1975;451-479
4. Baretta I.P., Assreuy J., De Lima T.C.M. Nitric oxide involvement in the anxiogenic-like effect of substance P. Behav. Brain Res. 121:2001;199-205
5. Belzung C., La Pape G. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Pysiol. Behav. 56:1994;623-628
6. Bernstein J.M. The role of the autonomic nervous system and inflammatory mediators in nasal hyperreactivity: a review. Otolaryngol. Head Neck Surg. 105:1991;596-607
7. Bitran D., Dowd J.A. Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology. 125(1):1996;65-75
8. Blanchard D.C., Griebel G., Blanchard R.J. Gender bias in the preclinical psychopharmacology of anxiety: male models for (predominantly) female disorders. J. Psychopharmacol. 9(2):1995;79-82
9. Blizard D.A., Lippman H.R., Chen J.J. Sex differences in open-field behavior in the rat: the inductive and activational role of gonadal hormones. Physiol. Behav. 14:1975;601-608
10. Cole J.C., Rodgers R.J. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology (Berl.). 114(2):1994;288-296
11. Comsa J., Leonhardt H., Wekerle H. Hormonal coordination of the immune response. Rev. Physiol. Biochem. Pharmacol. 92:1982;115-191
12. Cramer H., Rissler K., Rösler N., Strubel D., Schaudt D., Kuntzmann F. Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile Parkinsonian patients. Eur. Neurol. 29:1989;1-5
13. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49(1):1994;171-176
14. Dantzer R., Kelly K.W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 44:1989;1995-2008
15. Diaz-Véliz G., Soto V., Dussaubat N., Mora S. Influence of the estrous cycle, ovariectomy and estradiol replacement upon the acquisition of conditioned avoidance responses in rats. Physiol. Behav. 46(3):1989;397-401
16. DSM-IV - diagnostic and statistic manual of mental disorders. 4th ed:1994;American Psychiatric Association, Washington (DC)
17. Duval P., Lenoir V., Moussaoui S., Garret C., Kerdelhué B. Substance P and Neurokinin A variations throughout in the rat estrous cycle, comparison with ovariectomized and male rats: I. Plasma, hypothalamus, anterior and posterior pituitary. J. Neurosci. Res. 45:1996;598-609
18. Eglezos A., Andrews P.V., Boyd R.L., Helme R.D. Review: modulation of the immune response by tachykinins. Immunol. Cell Biol. 69:1991;285-294
19. Fernandes P.D., Assreuy J. Role of nitric oxide and superoxide in Giardia lamblia killing. Braz. J. Med. Biol. Res. 30(1):1997;93-99
20. File S.E. The biological basis of anxiety. Meltzer H.I., Nerozzi D. Pharmacotherapy of mental disorders. 1991;159-166 Elsevier, Amsterdam
21. File S.E. Anxiolytic action of a neurokinin 1 receptor antagonist in the social interaction test. Pharmacol. Biochem. Behav. 58:1997;747-752
22. File S., Wardill A.G. The reliability of the hole-board apparatus. Psychopharmacologia. 44(1):1975;47-51
23. Fonseca E.S., Massoco C.O., Palermo-Neto J. Effects of prenatal stress on stress-induced changes in behavior and macrophage activity of mice. Physiol. Behav. 77(2-3):2002;205-215
24. Frick K.M., Burlingame L.A., Arters J.A., Berger-Sweeney J. Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience. 95(1):2000;293-307
25. 1mRNA. Mol. Brain Res. 49:1997;157-164
26. Harkness J.E., Wagner J.E. The biology and medicine of rabbits and rodents. 4th ed:1995;260-265 Williams & Wilkins, Baltimore
27. Hoar W.S., Hickman C.P. General and comparative physiology. 2nd ed:1975;260-265 Prentice-Hall, Englewood Cliffs (NJ)
28. Hökfelt T., Broberger C., Xu Z.-Q.D., Sergeyev V.U.R., Diez M. Neuropeptides - an overview. Neuropharmacology. 39:2000;1337-1356
29. Iversen L.L. Central actions of substance P and related tachykinins. J. Psychopharmacol. 3:1989;1-6
30. Johnston A.L., File S.E. Sex differences in animal tests of anxiety. Physiol. Behav. 49:1991;245-250
31. Kanazawa I., Bird E., O'Conell R., Powell D. Evidence for a decrease in substance P content of substantia nigra in Huntington's chorea. Brain Res. 120:1977;387-392
32. Kelley A.E., Cador M., Stinus L. Exploration and its measurement. A psychopharmacological perspective. Boultonn A.A., Baker G.S., Greenshaw A.J. Neuromethods. 1993;Humana Press, Clinton, New Jersey
33. Kelly S.J., Ostrowski N.L., Wilson M.A. Gender differences in brain and behavior: hormonal and neural bases. Pharmacol. Biochem. Behav. 64(4):1999;664-665
34. Kramer M.S., Cutler N., Feigner F., Shrivastava R., Carman J., Sramek J.J., et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281:1998;1640-1645
35. Lapin I.P. Only controls: effect of handling, sham injection, and intraperitoneal injection of saline on behavior of mice in an elevated plus-maze. J. Pharmacol. Toxicol. Methods. 34(2):1995;73-77
36. Laursen S.E., Belknap J.P. Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Methods. 16:1987;155-157
37. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185
38. Maggi C.A. The effects of tachykinins on inflammatory and immune cells. Regul. Pept. 70:1997;75-90
39. Masur J., Schutz M.T., Boerngen R. Gender differences in open-field behavior as a function of age. Dev. Psychobiol. 13(2):1980;107-110
40. McGillis J.P., Organist M.L., Payan D.G. Substance P and immunoregulation. Fed. Proc. 46:1987;196-199
41. Morgan M.A., Pfaff D.W. Estrogen's effects on activity, anxiety, and fear in two mouse strains. Behav. Brain Res. 132:2002;85-93
42. Nelson R.J., Kriegsfeld L.J., Dawson V.L., Dawson T.M. Effects of nitric oxide on neuroendocrine function and behavior. Front. Neuroendocrinol. 18:1997;463-491
43. Nomikos G.C., Spyraki C. Influence of estrogen on spontaneous and diazepam-induced exploration of rats in an elevated plus-maze. Neuropharmacology. 27:1988;691-696
44. Otsuka M., Yoshioka L. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:1993;229-308
45. Palermo-Neto J., de Oliveira-Massoco C., Robespierre-de-Souza W. Effects of physical and psychological stressors on behavior, macrophage activity, and Ehrlich tumor growth. Brain Behav. Immun. 17(1):2003;43-54
46. Palma C., Manzini S. Substance P induces secretion of immunomodulatory cytokines by human astrocytoma cells. J. Neuroimmunol. 81:1998;127-137
47. Papp M., Vassout A., Gentsch C. The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats. Behav. Brain Res. 115:2000;19-23
48. Payan D.G., McGillis J.P., Organist M.L., Goetzl E.J. Neuroimmunology. Adv. Immunol. 39:1986;299-323
49. Powell D., Leeman S., Treagear G.W., Niall H.D., Potts J.T. Radioimmunoassay for substance P. Nat. News Biol. 241(112):1973;252-254
50. Raffa R.B. Possible role(s) of neurokinins in CNS development and neurodegenerative or other disorders. Neurosci. Biobehav. Rev. 22:1998;789-813
51. Ramos A., Berton O., Mormède P., Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav. Brain Res. 85:1997;57-69
52. Reddy D.S., Kulkarni S.K. Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats. Pharmacol. Biochem. Behav. 62:1999;53-60
53. 3 receptor modulation of experimental anxiety in mice. Neurosci. Lett. 258:1998;155-158
54. A receptors in the modulation of experimental anxiety by tachykinin agonists and antagonists in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 26:2002;861-869
55. 3 receptor involvement in the modulation of experimental anxiety in mice. Neuropeptides. 33:1999;181-188
56. Rocha F.F., Cysneiros R.M., Tanae M.M., Lima-Landman M.T.R., Lapa A.J., De Lima T.C.M. Influência do ciclo estral nos efeitos de uma fração ativa purificada de Cecropia glazioui Sneth no comportamento de ratas normotensas. XV Simpósio de Plantas Medicinais do Brasil, Águas de Lindóia, SP, Brazil. 1998;1-191
57. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci. Biobehav. Rev. 21(6):1997;801-810
58. Rodgers R.J., Cao B.J., Holmes A. Animal models of anxiety: an ethological perspective. Braz. J. Med. Biol. Res. 30:1997;204-299
59. Rugarn O., Hammar M., Theodorsson A., Theodorsson E., Stenfors C. Sex differences in neuropeptide distribution in the rat brain. Peptides. 20:1999;81-86
60. Schedlowski M., Benschop R.J. Neuroendocrine system and immune functions. Schedlowski M.E., Tewes U. Psychoneuroimmunology and Interdisciplinary Introduction. 1999;Kluver Academic/Plenum Publishers, New York, NY
61. Schmidt K., Mayer B., Kukovetz W.R. Effect of calcium on endothelium-derived relaxing factor formation and cGMP levels in endothelial cells. Eur. J. Pharmacol. 170(3):1989;157-166
62. Searles R.V., Yoo M.-J., He J.-R., Shen W.-B., Selmanoff M. Sex differences in GABA turnover and glutamic acid decarboxylase (GAD 65 and GAD 67) mRNA in the rat hypothalamus. Brain Res. 878:2000;11-19
63. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., Erspamer V. The tachykinin peptide family. Pharmacol. Rev. 54(2):2002;285-322
64. Teixeira R.M., De Lima T.C.M. Is there a relationship between behavioral changes and blood leukocyte distribution in stressed mice? From new molecules to new methods for health and knowledge in the beginning of a new millennium. 2000;1-301 Asociacion Latinoamericana de Farmacologia, São Paulo
65. Teixeira R.M., Santos A.R.S., Ribeiro S.J., Calixto J.B., Era G.A., De Lima T.C.M. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur. J. Pharmacol. 311:1996;7-14
66. Treit D. Animal models for the study of anti-anxiety agents: a review. Neurosci. Biobehav. Rev. 9:1985;203-222
67. Turrin N., Plata-Salaman C.R. Cytokine-cytokine interactions and the brain. Brain Res. Bull. 51(1):2000;3-9
68. Zhang Y., Lu L., Furlonger C., Wu G.E., Paige C.J. Hemokinin is a hematopoietic-specific tachykinin that regulates b lymphopoiesis. Nat. Immunol. 1:2000;329-397